NeuroPace, Inc. (NPCE) — Stock Score Summary

NeuroPace, Inc. (NPCE) has a MoatMap StockRank of 48/100 based on Quality (38/100), Value (36/100), and Momentum (60/100) factor scores. The current signal is HOLD. NeuroPace is a medical device company focused on epilepsy. It is currently unprofitable with high cash burn, failing our fundamental quality screens. We avoid early-stage medical technology with unproven commercial scale.

NeuroPace, Inc. is a medical device company focused on developing and commercializing its RNS System, an FDA-approved brain-responsive neurostimulation system for treating focal epilepsy that is not controlled by medication. The company holds a unique position with its personalized, closed-loop technology that monitors and responds to brain activity to prevent seizures. NeuroPace benefits from significant intellectual property and a specialized market within neurology, addressing a critical unmet need for patients.

Key Financial Metrics

Price$15.96
Market Cap$593M
P/E (Forward)-54.90
Price/Book28.78
Return on Equity-111.4%
Return on Invested Capital-16.0%
Debt/Equity487.49
Gross Margin78.3%
Operating Margin-25.2%
Revenue Growth-2.0%
Free Cash Flow$-3M

NeuroPace, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is NeuroPace, Inc.’s (NPCE) StockRank?
MoatMap’s StockRank for NeuroPace, Inc. (NPCE) is 48/100, with a Hold signal. It is a composite of Quality (38), Value (36), and Momentum (60) factor ranks across MoatMap’s 19,000+ stock universe.
Does NeuroPace, Inc. have an economic moat?
NeuroPace, Inc. (NPCE) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NeuroPace, Inc. a buy, hold, or sell?
MoatMap’s current signal for NeuroPace, Inc. (NPCE) is Hold, based on a StockRank of 48/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NeuroPace, Inc. in?
NeuroPace, Inc. (NPCE) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksNPCE deep dive reportAI ChampionsHow we score stocksSense-check another stock